Yarrow Bioscience Inc
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2015 | $-4.2M | $-4.2M | $0 | $65.0K |
| FY2016 | $-2.3M | $-2.3M | $31.0K | $573.0K |
| FY2017 | $-28.2M | $-28.2M | $27.0K | $5.3M |
| FY2018 | $-68.7M | $-69.2M | $567.0K | $5.3M |
| FY2019 | $-73.4M | $-74.5M | $1.1M | $4.9M |
| FY2020 | $-137.1M | $-137.2M | $113.0K | $18.1M |
| FY2021 | $-56.4M | $-56.4M | $0 | $8.1M |
| FY2022 | $-29.2M | $-29.2M | — | $4.3M |
| FY2023 | $-25.3M | $-25.3M | $0 | $3.3M |
| FY2024 | $-34.0M | $-34.1M | $117.0K | $3.3M |
| FY2025 | $-33.1M | $-33.1M | $0 | $2.3M |